• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为奥克兰新新西兰的德尔塔和奥密克戎变体的随机模型调查,接种疫苗状态对感染或感染 COVID-19 的可能性的影响。

Likelihood of infecting or getting infected with COVID-19 as a function of vaccination status, as investigated with a stochastic model for Aotearoa New Zealand for Delta and Omicron variants.

机构信息

Rutherford Postdoctoral Fellow, School of Earth and Environment, University of Canterbury, Christchurch, New Zealand; Postdoctoral Researcher, Department of Earth Sciences, University of Oregon Eugene, OR, USA.

出版信息

N Z Med J. 2022 Apr 1;135:89-100.

PMID:35728188
Abstract

AIM

The New Zealand Government has transitioned from the Alert Level framework, which relied on Government action and population level controls, to the COVID-19 Protection Framework, which relies on vaccination rates and allows for greater freedoms (for the vaccinated). Under the COVID-19 Protection Framework with and current widespread community transmission of Omicron, there is significant interest in understanding the relative risk of spreading COVID-19 posed by unvaccinated, vaccinated, and boosted individuals.

METHODS

A stochastic branching process model is used to simulate the spread of COVID-19 for outbreaks seeded by unvaccinated, vaccinated, or boosted individuals. The likelihood of infecting or getting infected with COVID-19 is calculated based on vaccination status. The model is applied to both the Delta and Omicron variants.

RESULTS

For the Delta variant, a vaccinated traveller infected with COVID-19 is 9x less likely to seed an outbreak than an unvaccinated traveller infected with COVID-19; however, for the Omicron variant, there is little difference between outbreaks seeded by unvaccinated and vaccinated individuals (boosted individuals are slightly less likely to seed large outbreaks). For the Delta variant, unvaccinated individuals are responsible for 87% of all infections whereas only 3% of infections are from vaccinated-to-vaccinated when normalised by population. Therefore, a vaccinated individual is 6.8x more likely to be infected by an unvaccinated individual than by a vaccinated individual. For the Omicron variant, unvaccinated individuals are responsible for 45% of all infections compared to 39% for vaccinated (two doses) and 15% for boosted (three doses) individuals when normalised by population. Despite the vaccine being less effective at preventing breakthrough transmission for Omicron, only 3% of all infections are from boosted-to-boosted individuals when normalised by population, indicating that three doses of the vaccine provides good protection from infection and breakthrough transmission.

CONCLUSIONS

This work demonstrates that most new infections are caused by unvaccinated individuals, especially for the Delta variant. These simulations illustrate the importance of vaccination in stopping individuals from becoming infected with COVID-19 and in preventing onward transmission. For Omicron, individuals vaccinated with two doses are only slightly less likely to spread COVID-19 than those who are unvaccinated. This work suggests that for the current Omicron outbreak the COVID-19 Protection Framework be updated to distinguish between those who have received two primary doses of the Pfizer-BioNTech vaccine (vaccinated individuals) and those who have received three doses (boosted individuals).

摘要

目的

新西兰政府已从依赖政府行动和人群层面管控的警戒级别框架过渡到依赖疫苗接种率的 COVID-19 保护框架,从而为(已接种疫苗的)人群提供更多自由。在 COVID-19 保护框架下,随着奥密克戎在社区的广泛传播,人们对了解未接种、接种和加强免疫人群传播 COVID-19 的相对风险产生了浓厚兴趣。

方法

使用随机分支过程模型模拟由未接种、接种或加强免疫个体引发的 COVID-19 传播。根据疫苗接种状况计算感染或感染 COVID-19 的可能性。该模型应用于德尔塔和奥密克戎变体。

结果

对于德尔塔变体,感染 COVID-19 的接种旅行者引发疫情的可能性比感染 COVID-19 的未接种旅行者低 9 倍;然而,对于奥密克戎变体,未接种和接种个体引发的疫情之间几乎没有差异(加强免疫个体引发大规模疫情的可能性略低)。对于德尔塔变体,未接种人群导致 87%的所有感染,而正常化到人群后,仅 3%的感染来自接种疫苗的人群。因此,接种个体被未接种个体感染的可能性是被接种个体感染的 6.8 倍。对于奥密克戎变体,正常化到人群后,未接种个体导致 45%的所有感染,而接种两剂疫苗的个体占 39%,接种三剂疫苗的个体占 15%。尽管疫苗在预防奥密克戎突破性传播方面的效果较差,但正常化到人群后,所有感染中仅有 3%来自加强免疫个体,这表明三剂疫苗可提供良好的感染和突破性传播保护。

结论

本研究表明,大多数新感染是由未接种人群引起的,尤其是对于德尔塔变体。这些模拟说明了疫苗接种在阻止个体感染 COVID-19 和阻止传播方面的重要性。对于奥密克戎,接种两剂疫苗的个体传播 COVID-19 的可能性略低于未接种个体。本研究表明,对于当前的奥密克戎疫情,需要对 COVID-19 保护框架进行更新,以区分已接种辉瑞-生物科技疫苗两剂(接种个体)和三剂(加强免疫个体)的人群。

相似文献

1
Likelihood of infecting or getting infected with COVID-19 as a function of vaccination status, as investigated with a stochastic model for Aotearoa New Zealand for Delta and Omicron variants.作为奥克兰新新西兰的德尔塔和奥密克戎变体的随机模型调查,接种疫苗状态对感染或感染 COVID-19 的可能性的影响。
N Z Med J. 2022 Apr 1;135:89-100.
2
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.mRNA COVID-19 疫苗 3 剂接种与 SARS-CoV-2 奥密克戎和德尔塔变异株引起的有症状感染之间的关联。
JAMA. 2022 Feb 15;327(7):639-651. doi: 10.1001/jama.2022.0470.
3
Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.与未接种疫苗的患者相比,使用主要生物标志物比较感染 SARS-CoV-2 Delta 或 Omicron VOC 患者的疾病严重程度和同源疫苗接种效果。
J Med Virol. 2022 Dec;94(12):5867-5876. doi: 10.1002/jmv.28098. Epub 2022 Sep 9.
4
A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株德尔塔迅速被奥密克戎取代:新冠病毒疾病病例数出现前所未有的激增,住院人数减少,上呼吸道病毒载量相当。
medRxiv. 2022 Jan 28:2022.01.26.22269927. doi: 10.1101/2022.01.26.22269927.
5
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.比较分析英国住院和死亡风险与 SARS-CoV-2 奥密克戎(B.1.1.529)和德尔塔(B.1.617.2)变异株的关系:一项队列研究。
Lancet. 2022 Apr 2;399(10332):1303-1312. doi: 10.1016/S0140-6736(22)00462-7. Epub 2022 Mar 16.
6
Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2.未接种疫苗和接种疫苗的个体中感染原始、Delta 或奥密克戎 SARS-CoV-2 的传染性病毒载量。
Nat Med. 2022 Jul;28(7):1491-1500. doi: 10.1038/s41591-022-01816-0. Epub 2022 Apr 8.
7
Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12-17 years in Singapore: a national cohort study.新加坡 12-17 岁青少年中针对 SARS-CoV-2 感染和住院的基础系列和加强针接种的有效性:一项全国队列研究。
Lancet Infect Dis. 2023 Feb;23(2):177-182. doi: 10.1016/S1473-3099(22)00573-4. Epub 2022 Sep 28.
8
Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants during two outbreaks from March to May 2022 in Quzhou, China.中国衢州 2022 年 3 月至 5 月两次疫情期间 COVID-19 疫苗对 SARS-CoV-2 奥密克戎变异株的有效性。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2163813. doi: 10.1080/21645515.2022.2163813. Epub 2023 Jan 27.
9
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study.英国未接种和接种疫苗人群中 SARS-CoV-2 德尔塔(B.1.617.2)变异株的社区传播和病毒载量动力学:一项前瞻性、纵向、队列研究。
Lancet Infect Dis. 2022 Feb;22(2):183-195. doi: 10.1016/S1473-3099(21)00648-4. Epub 2021 Oct 29.
10
Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.mRNA 疫苗接种与美国基本和前线工作人员中 COVID-19 的临床和病毒学特征的关联。
JAMA. 2022 Oct 18;328(15):1523-1533. doi: 10.1001/jama.2022.18550.